Welcome to the
National Cancer Institute - CRO Aviano Technology Transfer Office
Our mission is to strengthen the
economy from collaborations with private by moving results of
translational research into societal use.
Feel free to send us licensing requests or partnership proposals (incl.
project submissions to external funding agencies). A prompt answer and
strict confidentiality will be assured in all cases.
Ermes Mestroni, Technology Transfer Manager and Grant Specialist
CRO MEETS INDUSTRY 2012 exhibit was held on December 14th.
Researchers, biotech companies, business and community leaders
came together for a day of collaboration, bench-to-bedside
creativity, and real-world novel applications.
Right-click to download.
STARTUP OPPORTUNITY @Pordenone Fiere. Two research groups
from CRO Aviano translated life science innovation into
professional business plans (Onco-Target and D4D) to join the
brand new entrepreneurial competition (Punto di Incontro, 8-9
November 2012). Ready Chemio team delivered an Elevator Pitch.
INNOVATORS. Competition for the best ideas of applied research
developed in Italy, with relevant potential for the creation of
technology based companies. Awarded projects will be presented
during the 2013 edition of the Research Innovation and
Start-up activity at CRO is key in promotingregionaleconomicdevelopment.
It has raised more than 2 million euros since 2006.
The Technology Park of Pordenone hosts
entrepreneurial initiatives based on CRO Aviano novel technologies.
First Italian spin-off addressed to fight cancer through pharmacogenetics.
R&D intensive SME, PharmaDiagen S.r.l. produces devices predictive of
response to antitumor drugs based on patients' individual geneticprofile (pharmacogenetic Kits) and ICT-based tools with genetic
information that help clinicians choose proper drugs and doses (pharmacogenetic
Unique example within Italy's National Health Service of a high-tech
oriented company with an ownership share held by a public research
organisation or hospital.
Winner of the 2009 START CUP business plan competition.
Spin-off company founded by CRO researchers and
local entrepreneurs to bring advanced technologies for the
assessment of haemostasis on the market. Sedicidodici
S.r.l. and the National Cancer Institute CRO Aviano signed an agreement to
further develop the Smart Clot device. Patents in the
field of diagnosis and pharmacological monitoring of thrombotic,
ischemic and hemorragic pathology.
Our TTO is linked to innovation networks, marketplaces, and
stakholders looking for new business opportunities. Special
attention is devoted to education on Intellectual Property management
Click titles for details and previews shareable on Facebook, Twitter,
LinkedIn, etc. (if you use Internet Explorer please scroll to top).
Right-click to download flyers.
Cro Meets Industry
The first tech transfer showcase held at CRO Aviano on April 24th,